Imperial College

Tony Wood tritt die Nachfolge von Dr. Hal Barron als Chief Scientific Officer bei GlaxoSmithKline R&D an

Tony Wood übernimmt im August 2022 die volle Verantwortung für die F&E von GSK Hal Barron wechselt im August 2022…

2 years ago

Tony Wood to succeed Dr Hal Barron as Chief Scientific Officer at GlaxoSmithKline R&D

Tony Wood to assume full accountability for GSK R&D in August 2022 Hal Barron to transition in August 2022 from…

2 years ago

Pivoting for Success – the story of Plumis!

CAMBRIDGE, 25-Jul-2018 — /EuropaWire/ — Founded by Peter and Alan Cowley, The Invested Investor is aiming to increase the success rate…

6 years ago